THE VASOCONSTRICTOR ASSAY IN BIOEQUIVALENCE TESTING: PRACTICAL CONCERNS AND RECENT DEVELOPMENTS
- 1 October 1992
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 31 (s1), 26-28
- https://doi.org/10.1111/j.1365-4362.1992.tb04009.x
Abstract
The vasoconstrictor assay, when properly performed, is a highly reliable method to determine bioequivalence of generic formulations. Recent research has resolved some of the remaining questions concerning the practical application of the assay. Significant vehicle-related differences have been observed between the potency of different, supposedly equivalent formulations now on the market. Large differences in concentrations of the active agent in similar vehicles usually have not resulted in corresponding differences in vasoconstrictor assay results. Finally, the time course of drug effects may differ among highly potent and less potent corticosteroids. In general, the higher the potency of the topical corticosteroid, the earlier the maximal effect is observed. This finding suggests that short application of highly potent agents might minimize systemic absorption without sacrificing efficacy.Keywords
This publication has 11 references indexed in Scilit:
- A Double-blind Controlled Comparison of Generic and Trade-Name Topical Steroids Using the Vasoconstriction AssayArchives of Dermatology, 1991
- A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assayArchives of Dermatology, 1991
- Relation of application time to bioactivity of a potent topical glucocorticoid formulationJournal of the American Academy of Dermatology, 1990
- 'Vasoconstriction'--skin blanching--assay for glucocorticoids--a critiqueArchives of Dermatology, 1989
- Bioequivalence (bioavailability) of generic topical corticosteroidsJournal of the American Academy of Dermatology, 1989
- Are Generic Formulations Equivalent to Trade Name Topical Glucocorticoids?Archives of Dermatology, 1987
- Are generic formulations equivalent to trade name topical glucocorticoids?Archives of Dermatology, 1987
- Correlation of the vasoconstriction assay and clinical activity in psoriasisArchives of Dermatology, 1985
- Bioassay System for Formulations of Topically Applied GlucocorticosteroidsArchives of Dermatology, 1972
- Bioassay system for formulations of topically applied glucocorticosteroidsArchives of Dermatology, 1972